JP2026016543A5 - - Google Patents
Info
- Publication number
- JP2026016543A5 JP2026016543A5 JP2025178768A JP2025178768A JP2026016543A5 JP 2026016543 A5 JP2026016543 A5 JP 2026016543A5 JP 2025178768 A JP2025178768 A JP 2025178768A JP 2025178768 A JP2025178768 A JP 2025178768A JP 2026016543 A5 JP2026016543 A5 JP 2026016543A5
- Authority
- JP
- Japan
- Prior art keywords
- domain
- seq
- sequence numbers
- treg
- antigen recognition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1912515.2A GB201912515D0 (en) | 2019-08-30 | 2019-08-30 | Engineered regulatory T cell |
| GB1912515.2 | 2019-08-30 | ||
| JP2022513373A JP2022546457A (ja) | 2019-08-30 | 2020-08-28 | 改変された制御性ｔ細胞 |
| PCT/GB2020/052076 WO2021038249A1 (en) | 2019-08-30 | 2020-08-28 | Engineered regulatory t cell |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022513373A Division JP2022546457A (ja) | 2019-08-30 | 2020-08-28 | 改変された制御性ｔ細胞 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2026016543A JP2026016543A (ja) | 2026-02-03 |
| JP2026016543A5 true JP2026016543A5 (enExample) | 2026-05-21 |
Family
ID=68207135
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022513373A Pending JP2022546457A (ja) | 2019-08-30 | 2020-08-28 | 改変された制御性ｔ細胞 |
| JP2025178768A Pending JP2026016543A (ja) | 2019-08-30 | 2025-10-23 | 改変された制御性ｔ細胞 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022513373A Pending JP2022546457A (ja) | 2019-08-30 | 2020-08-28 | 改変された制御性ｔ細胞 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230134301A1 (enExample) |
| EP (1) | EP4021484A1 (enExample) |
| JP (2) | JP2022546457A (enExample) |
| KR (1) | KR20220051390A (enExample) |
| CN (1) | CN114585730A (enExample) |
| AU (1) | AU2020338290A1 (enExample) |
| CA (1) | CA3148676A1 (enExample) |
| GB (1) | GB201912515D0 (enExample) |
| IL (1) | IL290830A (enExample) |
| WO (1) | WO2021038249A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202217541D0 (en) * | 2022-11-24 | 2023-01-11 | Quell Therapeutics Ltd | Recombinant receptor |
| EP4442322A1 (en) | 2023-04-06 | 2024-10-09 | Medizinische Hochschule Hannover | Liver-specific car for use against immunologic rejection |
| CN118001381B (zh) * | 2024-01-24 | 2025-04-22 | 首都医科大学附属北京地坛医院 | 一种药物组合物及应用 |
| WO2026027876A1 (en) * | 2024-07-29 | 2026-02-05 | Quell Therapeutics Limited | Chimeric antigen receptor |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9803351D0 (en) | 1998-02-17 | 1998-04-15 | Oxford Biomedica Ltd | Anti-viral vectors |
| GB0009760D0 (en) | 2000-04-19 | 2000-06-07 | Oxford Biomedica Ltd | Method |
| JP2013516967A (ja) * | 2010-01-14 | 2013-05-16 | グラクソ グループ リミテッド | 肝臓標的化ドメイン抗体 |
| GB201108236D0 (en) * | 2011-05-17 | 2011-06-29 | Ucl Business Plc | Method |
| CN105713881B (zh) * | 2014-12-04 | 2019-12-06 | 科济生物医药（上海）有限公司 | 双靶向gpc3和asgpr1的转基因免疫效应细胞及其应用 |
| US10336810B2 (en) * | 2015-02-12 | 2019-07-02 | University Health Network | Chimeric antigen receptors, encoding nucleic acids and methods of use thereof |
| EP3331918A1 (en) * | 2015-08-04 | 2018-06-13 | GlaxoSmithKline Intellectual Property Development Limited | Combination treatments and uses and methods thereof |
| CN105331585A (zh) * | 2015-11-13 | 2016-02-17 | 科济生物医药（上海）有限公司 | 携带pd-l1阻断剂的嵌合抗原受体修饰的免疫效应细胞 |
| AU2016427822B2 (en) * | 2016-10-31 | 2025-01-23 | Seattle Children's Hospital (dba Seattle Children's Research Institute) | Method for treating autoimmune disease using CD4 T-cells with engineered stabilization of expression of endogennous FOXP3 gene |
| CA3088832A1 (en) * | 2018-01-19 | 2019-07-25 | Miltenyi Biotec B.V. & Co. KG | Regulatory t cell expressing a chimeric antigen receptor |
| WO2019241549A1 (en) | 2018-06-15 | 2019-12-19 | A2 Biotherapeutics, Inc. | Foxp3-expressing car-t regulatory cells |
-
2019
- 2019-08-30 GB GBGB1912515.2A patent/GB201912515D0/en not_active Ceased
-
2020
- 2020-08-28 AU AU2020338290A patent/AU2020338290A1/en active Pending
- 2020-08-28 EP EP20767594.3A patent/EP4021484A1/en active Pending
- 2020-08-28 KR KR1020227010359A patent/KR20220051390A/ko active Pending
- 2020-08-28 CA CA3148676A patent/CA3148676A1/en active Pending
- 2020-08-28 CN CN202080072135.2A patent/CN114585730A/zh active Pending
- 2020-08-28 JP JP2022513373A patent/JP2022546457A/ja active Pending
- 2020-08-28 WO PCT/GB2020/052076 patent/WO2021038249A1/en not_active Ceased
- 2020-08-28 US US17/639,056 patent/US20230134301A1/en active Pending
-
2022
- 2022-02-23 IL IL290830A patent/IL290830A/en unknown
-
2025
- 2025-10-23 JP JP2025178768A patent/JP2026016543A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10647770B2 (en) | Therapeutic agent for autoimmune diseases comprising PD-1 agonist | |
| JP2025183279A5 (enExample) | ||
| JP2022061992A5 (enExample) | ||
| JP6908591B2 (ja) | Ｉｌ２ｒベータ／共通ガンマ鎖抗体 | |
| JP6719477B2 (ja) | 抗ｔｉｍ−３抗体 | |
| US10259874B2 (en) | Anti-TIM-3 antibodies | |
| JP2022531911A5 (enExample) | ||
| JP2022546457A5 (enExample) | ||
| US20220251221A1 (en) | Il2rbeta/common gamma chain antibodies | |
| JP2022543387A5 (enExample) | ||
| JP2021530236A5 (enExample) | ||
| WO2017020812A1 (zh) | 抗磷脂酰肌醇蛋白多糖-3的抗体及其应用 | |
| JP2023519099A5 (enExample) | ||
| JP2012501670A5 (enExample) | ||
| JP2023551027A5 (enExample) | ||
| JP2021511041A5 (enExample) | ||
| CN116789820A (zh) | 一种新型免疫调节剂的开发和应用 | |
| JP7461875B2 (ja) | 病気の症状の治療又は予防に使用するための抗アドレノメデュリン（ａｄｍ）バインダー | |
| JP2024507540A5 (enExample) | ||
| CN116836269A (zh) | 抗呼吸道合胞病毒的单克隆抗体及其应用 | |
| RS63580B1 (sr) | Humanizovana antitela protiv clever-1 i njihova primena | |
| CN108276492A (zh) | 抗pd－l1单克隆抗体及其应用 | |
| CN108314734A (zh) | 抗pd－1单克隆抗体及其应用 | |
| TWI910636B (zh) | 特異性結合cll1的抗體及其製法和應用 | |
| CN116854820B (zh) | Pd-1非阻断性清除抗体及其用途 |